Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Blue California completes groundbreaking human clinical trial on ErgoActive® ergothioneine intervention for cognitive function, memory, and sleep

Contributed by: GlobeNewswire

Tags

clinical trial cognition

More Like This

FutureCeuticals Announces Publication of Groundbreaking Study on CognatiQ®'s Same-Day Cognitive Benefits

First Intervention Shown to Lower Alzheimer’s and Dementia Incidence

PR Newswire associated0

BioQ Debuts at in‑cosmetics Global, Showcasing China's Advancing Strength in Ingredient Innovation

Gabather reports initial positive results from the EEG/fMRI target engagement study

PR Newswire associated0

REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY

GlobeNewswire associated0

Brain Training Shown to Reduce Amyloid Indicative of Alzheimer’s

PR Newswire associated0

Study Finds Lycomato® Improves Mitochondrial Function and Delays Cellular Aging

ACCESSWIRE logo

WholisticResearch Reveals the Best Nootropics of 2023

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us